Newsroom

Categories: Biomanufacturing, Pharma, Corporate, Finance & Investor

New Lonza Webinar — “Taking the Leap into an MES from a CEO’s Perspective”

April 20, 2023

Categories: Healthcare, Pharma, Corporate, Finance & Investor

Tillotts Pharma AG announces the launch of Octasa® 1600 mg Tablets in Canada

April 6, 2023

Categories: Biotechnology, Pharma, Corporate, Finance & Investor

Remedium and Exothera partner on scale-up and demonstration runs for AAV2-FGF18

March 22, 2023

Categories: Drug Discovery & Development, Pharma, Corporate, Finance & Investor

NDA Group welcomes Marianne Scheel Fjording, Ph.D. to the NDA Advisory Board adding essential expertise in bioanalysis and immunogenicity assessment to the team

March 7, 2023

Categories: Biotechnology, Computing & Technology, Pharma

pharma& chooses Generis’ CARA Life Sciences Platform to become the basis of its Regulatory, Quality and Legal Management System

February 22, 2023

Categories: Biotechnology, Pharma

TransCure bioServices offers BioVolume 3D imaging for insightful preclinical oncology research

February 2, 2023

Categories: Biotechnology, Pharma, Corporate, Finance & Investor

Exothera announces the appointment of Darren Leva as Chief Business Officer

February 1, 2023

Categories: Computing & Technology, Pharma, Corporate, Finance & Investor

German pharma company selects Generis’ CARA Life Sciences Platform to unify their clinical processes

January 18, 2023

Categories: Computing & Technology, Pharma, Corporate, Finance & Investor

Global pharmaceutical company Merz choose Generis’ CARA Life Sciences Platform to consolidate their R&D content

December 19, 2022